vimarsana.com

Page 2 - Utah Based Recursion News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Baystreet ca - Nvidia Buys into Recursion

Baystreet ca - Nvidia Buys into Recursion
baystreet.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from baystreet.ca Daily Mail and Mail on Sunday newspapers.

Nvidia Invests $50 Million in Biotech Company Recursion for AI Drug Discovery

Nvidia is investing in Recursion, which uses AI models to identify new therapies and offers those models to its partners, including Roche and Bayer.

Recursion stock extends gains in AI-led rally (NASDAQ:RXRX)

Recursion Pharma (RXRX) shares jumped for the second straight session on Tuesday to double its value this month amid interest in AI led drug discovery. Read more here.

5 Firms Lead Trio of Biotech IPOs Raising $721M Combined

ADVERTISEMENT ADVERTISEMENT 5 Firms Lead Trio of Biotech IPOs Raising $721M Combined Law360 (April 16, 2021, 6:02 PM EDT) Three biotechnology firms went public to receptive investors Friday after raising $721 million combined in initial public offerings guided by five law firms, led by an upsized offering by Recursion Pharmaceuticals Inc., which uses artificial intelligence to develop rare disease treatments. Recursion, advised by Wilson Sonsini Goodrich & Rosati PC, raised $436.4 million after selling 24.2 million shares at $18 each, hitting the peak of its price range of $16 to $18 per share. The venture-backed company also beefed up its deal from original plans to sell 18 million shares. Salt Lake City, Utah-based Recursion uses artificial intelligence, machine learning and.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.